Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
OXA-232 carbapenemase is becoming a threat in China due to its high prevalence, mortality, and limited treatment options. However, little information is available on the impact of OXA-232-producing Klebsiella pneumoniae in China. This study aims to characterize the clonal relationships, the genetic mechanisms of resistance, and the virulence of OXA-232-producing K. pneumoniae isolates in China. We collected 81 OXA-232-producing K. pneumoniae clinical isolates from 2017 to 2021. Antimicrobial susceptibility testing was performed using the broth microdilution method. Capsular types, multilocus sequence types, virulence genes, antimicrobial resistance (AMR) determinants, plasmid replicon types, and single-nucleotide polymorphism (SNP) phylogeny were inferred from whole-genome sequences. OXA-232-producing K. pneumoniae strains were resistant to most antimicrobial agents. These isolates showed partial differences in susceptibility to carbapenems: all strains were resistant to ertapenem, while the resistance rates to imipenem and meropenem were 67.9% and 97.5%, respectively. Sequencing and capsular diversity analysis of the 81 K. pneumoniae isolates revealed 3 sequence types (ST15, ST231, and one novel ST [ST-V]), 2 K-locus types (KL112 and KL51), and 2 O-locus types (O2V1 and O2V2). The predominant plasmid replicon types associated with the OXA-232 and genes were ColKP3 (100%) and IncFIB-like (100%). Our study summarized the genetic characteristics of OXA-232-producing K. pneumoniae circulating in China. The results demonstrate the practical applicability of genomic surveillance and its utility in providing methods to prevent transmission. It alerts us to the urgent need for longitudinal surveillance of these transmissible lineages. In recent years, the detection rate of carbapenem-resistant K. pneumoniae has increased and represents a major threat to clinical anti-infective therapy. Compared with KPC-type carbapenemases and NDM-type metallo-β-lactamases, OXA-48 family carbapenemases are another important resistance mechanism mediating bacterial resistance to carbapenems. In this study, we investigated the molecular characteristics of OXA-232 carbapenemase-producing K. pneumoniae isolated from several hospitals to clarify the epidemiological dissemination characteristics of such drug-resistant strains in China.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10269757 | PMC |
| http://dx.doi.org/10.1128/spectrum.03863-22 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
High frequency of acquired virulence factors in carbapenemase-producing isolates from a large German university hospital, 2013-2021.
Antimicrob Agents Chemother
November 2024
Institute of Medical Microbiology and Virology, University of Oldenburg, Oldenburg, Germany.
Carbapenemase-producing (CP-Kp) isolates are a public health concern as they can cause severe hospital-acquired infections that are difficult to treat. It has recently been shown that CP-Kp can take up virulence factors from hypervirulent lineages. In this study, 109 clinical CP-Kp isolates from the University Hospital Cologne were examined for the presence of acquired virulence factors using whole-genome sequencing and phenotypic tests, and results were linked to clinical data.
View Article and Find Full Text PDFEarly detection of OXA-232-producing Klebsiella pneumoniae in China predating its global emergence.
Microbiol Res
May 2024
State Key Lab of Chemical Biology and Drug Discovery and the Department of Food Science and Nutrition, The Hong Kong Polytechnic University, Kowloon, Hong Kong Special Administrative Region; Shenzhen Key Laboratory of Food Biological Safety Control, The Hong Kong Polytechnic University Shenzhen Re
Antibiotic resistance is a global health issue, with Klebsiella pneumoniae (KP) posing a particular threat due to its ability to acquire resistance to multiple drug classes rapidly. OXA-232 is a carbapenemase that confers resistance to carbapenems, a class of antibiotics often used as a last resort for treating severe bacterial infections. The study reports the earliest known identification of six OXA-232-producing KP strains that were isolated in Zhejiang, China, in 2008 and 2009 within a hospital, two years prior to the first reported identification of OXA-232 in France.
View Article and Find Full Text PDFOuter membrane vesicles mediating horizontal transfer of the epidemic carbapenemase gene among .
Emerg Microbes Infect
December 2024
Department of Laboratory Medicine, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, People's Republic of China.
OXA-232 is one of the most common OXA-48-like carbapenemase derivatives and is widely disseminated in nosocomial settings across countries. The gene is located on a 6-kb non-conjugative ColKP3-type plasmid, while the dissemination of into different species and the polyclonal dissemination of OXA-232-producing revealed the horizontal transfer of . However, it's still unclear how this non-conjugative ColKP3 plasmid could facilitate the mobilization of .
View Article and Find Full Text PDFPopulation genomic analysis of clinical ST15 strains in China.
Front Microbiol
November 2023
Jiyang College, Zhejiang A&F University, Zhuji, China.
ST15 (Kpn) is a growing public health concern in China and worldwide, yet its genomic and evolutionary dynamics in this region remain poorly understood. This study comprehensively elucidates the population genomics of ST15 Kpn in China by analyzing 287 publicly available genomes. The proportion of the genomes increased sharply from 2012 to 2021, and 92.
View Article and Find Full Text PDFOutbreak of OXA-232-producing carbapenem-resistant ST15 in a Chinese teaching hospital: a molecular epidemiological study.
Front Cell Infect Microbiol
September 2023
Department of Laboratory Medicine, the Second Affiliated Hospital of Jiaxing University, Jiaxing, Zhejiang, China.
Article Synopsis
- The study focuses on the rising incidence of OXA-232-producing carbapenem-resistant Klebsiella pneumoniae (CRKP) in China, particularly through the first outbreak in a specific hospital from February 2021 to March 2022.
- Researchers collected and analyzed 21 clinical isolates from 16 patients, uncovering clonal transmission and shared drug resistance profiles among the strains.
- The analysis indicated that most transmission occurred in the ICU and linked the outbreak to earlier cases in nearby cities, revealing new resistance genes due to genetic changes in plasmids between two identified clusters of infections.